Metformin, a drug used to treat diabetes and also women with Polycystic Ovary syndrome (PCOS), may potentially provide protection against endometrial cancer, researchers at the University of Warwick have found.
Endometrial cancer is the most common malignancy of the female genital tract and the fourth most common cancer in women in the UK and the US.
Recent research has found that Metformin has anti-cancer properties e.g. in breast cancer. Given that insulin resistant states, e.g. obesity, ...
Metformin, a drug used to treat diabetes and also women with Polycystic Ovary syndrome (PCOS), may potentially provide protection against endometrial cancer, researchers at the University of Warwick have found.
Endometrial cancer is the most common malignancy of the female genital tract and the fourth most common cancer in women in the UK and the US.
Recent research has found that Metformin has anti-cancer properties e.g. in breast cancer. Given that insulin resistant states, e.g. obesity, ...